ArticleBlood advances2019

Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

Luise Goldmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.